Unknown PHASE4 INTERVENTIONAL 2-arm NCT03288428

Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy

Sponsor: Peking University First Hospital

Updated 7 times since 2017 Last updated: Nov 1, 2017 Started: May 1, 2017 Primary completion: Dec 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03288428, this PHASE4 trial focuses on Postoperative Pain and remains ongoing. Sponsored by Peking University First Hospital, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Dec 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Dec 2019 [monthly]

Recruiting PHASE4

▶ Show 2 earlier versions

Dec 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Oct 2017 — Dec 2017 [monthly]

Recruiting PHASE4

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking University First Hospital

Data source: Peking University First Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China